Triumph Science&Technology Co Current Liabilities
The Current Liabilities of Triumph Science&Technology Co (600552.SS) as of Oct 4, 2026 is 1.92 B CNY. In the previous year, Current Liabilities was 5.68 B CNY — a change of -66.25% (lower).
Get this data via API
Financial Data API
Current Liabilities
1.92 BCNY
YoY
-66.25%
Last updated:
The Triumph Science&Technology Co Current Liabilities history
3 Years
10 Years
25 Years
Max
| YEAR | Current Liabilities | YoY |
|---|---|---|
| 1.92 BCNY | -66.25% | |
| 5.68 BCNY | -2.43% | |
| 5.82 BCNY | +16.98% | |
| 4.98 BCNY | +17.22% | |
| 4.25 BCNY | -17.77% | |
| 5.16 BCNY | +53.85% | |
| 3.36 BCNY | -12.02% | |
| 3.82 BCNY | +94.41% | |
| 1.96 BCNY | -4.72% | |
| 2.06 BCNY | -4.70% | |
| 2.16 BCNY | +276.95% | |
| 573.38 MCNY | +31.91% | |
| 434.69 MCNY | +8.31% | |
| 401.32 MCNY | -14.22% | |
| 467.87 MCNY | +85.90% | |
| 251.68 MCNY | -22.08% | |
| 323.00 MCNY | -6.81% | |
| 346.62 MCNY | +3.01% | |
| 336.48 MCNY | -6.89% | |
| 361.36 MCNY | -1.01% | |
| 365.04 MCNY | +6.00% | |
| 344.36 MCNY | -2.73% | |
| 354.03 MCNY | +154.70% | |
| 139.00 MCNY | +32.04% | |
| 105.27 MCNY | +9.32% | |
| 96.29 MCNY | — | |
| 0.00CNY | — |
Triumph Science&Technology Co Stock analysis
Frequently Asked Questions about Triumph Science&Technology Co stock
Current Liabilities of Triumph Science&Technology Co is 1.92 B CNY in 2026.
Current Liabilities of Triumph Science&Technology Co changed from 5.68 B CNY to 1.92 B CNY, representing a -66.25% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Current Liabilities Triumph Science&Technology Co since 2006 – with annual values, charts, and detailed analysis.
Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.
Current Liabilities's CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Triumph Science&Technology Co historically and in real time.
Balance Sheet — Triumph Science&Technology Co
All Key Metrics — Triumph Science&Technology Co
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth